Companies throw their weight behind new antiobesity drugs.
- Published in:
- Nature Medicine, 2010, v. 16, n. 2, p. 136, doi. 10.1038/nm0210-136a
- By:
- Publication type:
- Article
Works matching DE "OREXIGEN Therapeutics Inc."
Results: 5
1
2
Novel pharmacotherapies for obesity poised to enter market.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 833, doi. 10.1038/nrd3044
- By:
- Publication type:
- Article
3
What patent practitioners can learn from Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.
- Published in:
- Journal of Intellectual Property Law & Practice, 2021, v. 16, n. 9, p. 1000, doi. 10.1093/jiplp/jpab068
- By:
- Publication type:
- Article
4
Naltrexone/Bupropion.
- Published in:
- Drugs in R&D, 2010, v. 10, n. 1, p. 25
- Publication type:
- Article
5
Seven days: 4?10 February 2011.
- Published in:
- Nature, 2011, v. 470, n. 7333, p. 144, doi. 10.1038/470144a
- Publication type:
- Article